Circulation

JUNE 4, 2024

BACKGROUND:Cardiovascular disease and stroke are common and costly, and their prevalence is rising. to 26.8%) and obesity (43.1% to 3.8%), stroke (3.9% Clinical and public health interventions are needed to effectively manage, stem, and even reverse these adverse trends. Circulation, Ahead of Print.

Risk Factors 81

Risk Factors Cardiovascular Disease Stroke Strokes 81

Circulation

JANUARY 24, 2024

METHODS:The AHA, through its Epidemiology and Prevention Statistics Committee, continuously monitors and evaluates sources of data on heart disease and stroke in the United States and globally to provide the most current information available in the annual Statistical Update with review of published literature through the year before writing.

Heart Disease 81

Heart Disease Stroke Strokes Peripheral Arterial Disease 81

ADN Center of Excellence

SEPTEMBER 2, 2024

This miscommunication can cause blood to pool in the atria, increasing the risk of clot formation, which can then lead to strokes. AFib is associated with a fivefold increased risk of stroke, and it is also linked to heart failure, chronic fatigue, and other serious health issues.

AFIB 59

AFIB Atrial Fibrillation Innovation Education 59

DAIC

SEPTEMBER 11, 2024

Atrial fibrillation, a rapid, irregular heart beat that can lead to stroke or sudden death, is three times more common than previously thought, affecting nearly 5 percent of the population, or 10.5 Studies have shown that people with A-Fib are up to 5 times more likely to have a stroke. tim.hodson Wed, 09/11/2024 - 15:40 Sept.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Cardiology Update

JANUARY 24, 2024

Growing Global Burden of Cardiometabolic Risks: The 2023 World Obesity Atlas projects a significant rise in global overweight and obesity levels by 2035, leading to a surge in diabetes cases. The findings have significant implications for clinical and public health practice and research.

Cardiovascular Disease 119

Cardiovascular Disease Research Blood Pressure Public Health 119

Cardiometabolic Health Congress

SEPTEMBER 29, 2023

Cardiometabolic Health Congress faculty member, Fátima Rodriguez, MD, MPH, has committed much of her clinical and research efforts to reducing health disparities in Hispanic-American communities. Cardiometabolic conditions – specifically obesity, diabetes and heart disease – disproportionately affect the 60 million people in the U.S.

Health Disparities 52

Health Disparities Obesity Heart Disease Cardiovascular Disease 52

DAIC

MARCH 8, 2024

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111

Obesity Heart Disease Heart attacks Heart Attack 111